Chai Christopher Y

Chief Financial Officer at Principia Biopharma Inc.; Chief Financial Officer at MAP Pharmaceuticals, Inc.

Sold, on record
$3.3M
Dollars the filings state
Form 4 sales
11
Latest Aug 18, 2020
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale MAP Pharmaceuticals, Inc.Unusual
    Mar 24, 2010 2010

    Sold 16,000 shares at $16.60 ($266k)

    Chai Christopher Y, Chief Financial Officer

    Sold 70.5% of holdings ($377k position)6,709 shares left1.6x usual sizeFiling

  2. 2 Form 4 sale MAP Pharmaceuticals, Inc.Unusual
    May 20, 2010 +57 days

    Sold 16,000 shares at $14.77 ($236k)

    Chai Christopher Y, Chief Financial Officer

    Sold 70.5% of holdings ($335k position)6,709 shares left1.6x usual sizeFiling

  3. 3 Form 4 sale MAP Pharmaceuticals, Inc.Unusual
    Jul 21, 2010 +62 days

    Sold 16,000 shares at $12.71 ($203k)

    Chai Christopher Y, Chief Financial Officer

    Sold 70.5% of holdings ($289k position)6,709 shares left1.6x usual sizeFiling

  4. 4 Form 4 sale MAP Pharmaceuticals, Inc.Unusual
    Sep 20, 2010 +61 days

    Sold 16,000 shares at $14.05 ($225k)

    Chai Christopher Y, Chief Financial Officer

    Sold 70.5% of holdings ($319k position)6,709 shares left1.2x usual sizeFiling

  5. 5 Form 4 sale MAP Pharmaceuticals, Inc.Unusual
    Sep 20, 2011 +365 days

    Sold 32,000 shares at $15.38 ($492k)

    Chai Christopher Y, Chief Financial Officer

    Sold 80.6% of holdings ($611k position)7,703 shares left2x usual sizeFiling

  6. 6 Form 4 sale Principia Biopharma Inc.Unusual
    Feb 18, 2020 +3073 days

    Sold 7,500 shares at $65.89 ($494k)

    Chai Christopher Y, Chief Financial Officer

    Sold 61.1% of holdings ($808k position)4,766 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale Principia Biopharma Inc.Unusual
    May 19, 2020 +91 days

    Sold 7,500 shares at $65.10 ($488k)

    Chai Christopher Y, Chief Financial Officer

    Sold 67.9% of holdings ($719k position)3,539 shares leftFiling

  8. 8 Form 4 sale Principia Biopharma Inc.Unusual
    Aug 18, 2020 +91 days

    Sold 7,500 shares at $99.37 ($745k)

    Chai Christopher Y, Chief Financial Officer

    Sold 67.9% of holdings ($1.1M position)3,539 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Chai Christopher Y
Source
Aug 18, 2020Aug 20, 2020Principia Biopharma Inc.Chief Financial OfficerForm 4 sale7,500$745k67.9%UnusualSEC
May 19, 2020May 21, 2020Principia Biopharma Inc.Chief Financial OfficerForm 4 sale7,500$488k67.9%UnusualSEC
Feb 18, 2020Feb 20, 2020Principia Biopharma Inc.Chief Financial OfficerForm 4 sale7,500$494k61.1%UnusualSEC
Sep 20, 2011Sep 22, 2011MAP Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale32,000$492k80.6%UnusualSEC
Sep 20, 2010Sep 22, 2010MAP Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale16,000$225k70.5%UnusualSEC
Jul 21, 2010Jul 22, 2010MAP Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale16,000$203k70.5%UnusualSEC
May 20, 2010May 21, 2010MAP Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale16,000$236k70.5%UnusualSEC
Mar 24, 2010Mar 25, 2010MAP Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale16,000$266k70.5%UnusualSEC
Nov 2, 2009Nov 4, 2009MAP Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale10,000$81k66.8%UnusualSEC
Oct 1, 2009Oct 5, 2009MAP Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale10,000$103k66.8%UnusualSEC
Feb 9, 2009Feb 11, 2009MAP Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale21$273100.0%UnusualSEC